NCT06874634View on ClinicalTrials.gov

Albumin Infusion Targets on Mortality in Patients With Abdominal Sepsis

CompletedOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2025

Conditions
28-day Mortality
Interventions
DRUG

Human serum albumin injection

Infusion of human albumin injection into patients with abdominal sepsis admitted to the ICU

Trial Locations (1)

510515

Department of Critical Care Medicine, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER

NCT06874634 - Albumin Infusion Targets on Mortality in Patients With Abdominal Sepsis | Biotech Hunter | Biotech Hunter